Literature DB >> 12755656

Prevalence of hepatitis A, hepatitis B, and HIV among hepatitis C-seropositive state hospital patients: results from Oregon State Hospital.

Jonathan M Meyer1.   

Abstract

BACKGROUND: Multiple studies have shown that individuals with severe mental illness are at increased risk for acquiring infection from human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV). Moreover, patients with chronic HCV infection are at risk for fulminant hepatitis from acquired infection with hepatitis A virus (HAV) or HBV, but there are limited data on the prevalence of HIV, HAV, and HBV in chronically hospitalized U.S. psychiatric patients without mental retardation who are HCV-seropositive. To address this issue, a comprehensive screening program was commenced at Oregon State Hospital (Salem, Ore.) beginning in 1999.
METHOD: The computerized records of all non-geriatric adult inpatients at Oregon State Hospital on April 23, 2001, were reviewed to assess physician compliance with screening and the prevalence of infection with HIV, HAV, HBV, and HCV.
RESULTS: Among the 535 patient records reviewed, 94.8% of patients were screened for HCV, of whom 20.3% were seropositive. Among HCV-seropositive patients, only 1.9% were not screened for HAV and HBV, but 23.3% were not tested for HIV. In the HCV-seropositive group, 35.9% were HAV-positive, 49.5% HBV-positive, and 2.6% HIV-positive.
CONCLUSION: Chronic psychiatric inpatients have high HCV prevalence rates. Hepatitis C-seropositive individuals may be at risk for complications unless vaccinated for HAV and HBV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12755656     DOI: 10.4088/jcp.v64n0507

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  14 in total

1.  Understanding associations between serious mental illness and hepatitis C virus among veterans: a national multivariate analysis.

Authors:  Seth Himelhoch; John F McCarthy; Dara Ganoczy; Deborah Medoff; Amy Kilbourne; Richard Goldberg; Lisa Dixon; Frederic C Blow
Journal:  Psychosomatics       Date:  2009 Jan-Feb       Impact factor: 2.386

2.  Estimating HCV prevalence at the state level: a call to increase and strengthen current surveillance systems.

Authors:  Rachel Hart-Malloy; Alvaro Carrascal; A Gregory Dirienzo; Colleen Flanigan; Kristi McClamroch; Lou Smith
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

3.  Hepatitis C services and individuals with serious mental illness.

Authors:  Richard W Goldberg; Puja Seth
Journal:  Community Ment Health J       Date:  2008-05-09

4.  Toward a more accurate estimate of the prevalence of hepatitis C in the United States.

Authors:  Brian R Edlin; Benjamin J Eckhardt; Marla A Shu; Scott D Holmberg; Tracy Swan
Journal:  Hepatology       Date:  2015-08-25       Impact factor: 17.425

5.  SCREENING FOR AND PREVALENCE OF HIV AND HEPATITIS C AMONG AN OUTPATIENT URBAN SAMPLE OF PEOPLE WITH SERIOUS MENTAL ILLNESS AND CO-OCCURRING SUBSTANCE ABUSE.

Authors:  Seth Himelhoch; Richard Goldberg; Christine Calmes; Deborah Medoff; Eric Slade; Lisa Dixon; Gerard Gallucci; Stanley Rosenberg
Journal:  J Community Psychol       Date:  2011-02-02

6.  The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.

Authors:  Maria Ferrara; Anya Umlauf; Chelsea Sanders; Jonathan M Meyer; John Allen McCutchan; Nichole Duarte; Joseph Hampton Atkinson; Igor Grant; Ronald J Ellis
Journal:  Psychiatry Res       Date:  2014-04-18       Impact factor: 3.222

7.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

8.  Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use.

Authors:  Seth Himelhoch; Geetanjali Chander; John A Fleishman; James Hellinger; Paul Gaist; Kelly A Gebo
Journal:  Gen Hosp Psychiatry       Date:  2007 Nov-Dec       Impact factor: 3.238

9.  Behavioral and social correlates of methamphetamine use in a population-based sample of early and later adolescents.

Authors:  Dennis Embry; Martin Hankins; Anthony Biglan; Shawn Boles
Journal:  Addict Behav       Date:  2008-11-27       Impact factor: 3.913

Review 10.  HIV testing among individuals with a severe mental illness: review, suggestions for research, and clinical implications.

Authors:  T E Senn; M P Carey
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.